ISB News

In this deep-dive episode, Matt Kaberlein sits down with Sean Gibbons, one of the leading researchers in human microbiome science, to explore the complexity, nuance, and emerging applications of gut microbiome research. They cover both foundational and cutting-edge topics.

In this hour-long video interview, Sui Huang discusses his paradigm-changing ideas for how we understand cancer and how they can influence how the disease is treated.

Sean Gibbons spoke with Science Focus about the link between the frequency of bowel movements and long-term health.

Infrequent pooping may be setting yourself up for medical problems down the road, and pooping too often brings its own issues. Research out of the Gibbons Lab details the “Goldilocks” zone.

Personalized pre/probiotic treatments could someday be used to support healthy sleep through stressful exam periods and menopause, a new review by Gibbons Lab scientists suggests.

Research from the Heath and Wei labs has uncovered the rapid cellular mechanisms that melanoma cells employ to develop resistance to the cancer drug vemurafenib. By closely examining the initial hours and days after drug exposure, the study reveals how cancer cells activate a backup communication system to bypass the drug’s effects, suggesting potential new combination treatment strategies to overcome this resistance.